Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2016*

Pharma company ranking based on access to medicine in developing countries 2016 This statistic depicts the Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2016. In that year, GlaxoSmithKline with 3.43 had the highest total score. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Loading statistic...
Expand statistic
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc3.43
Johnson & Johnson2.93
Novartis AG2.87
Merck KGaA2.83
Merck & Co Inc.2.65
Sanofi2.58
AstraZeneca plc2.53
Gilead Sciences2.45
AbbVie Inc.2.39
Novo Nordisk A/S2.35
Eisai Co. Ltd.2.34
Bayer AG2.03
Bristol-Meyers Squibb Co.1.97
Pfizer Inc.1.87
Takeda Pharmaceutical Co.1.77
Boehringer-Ingelheim GmbH1.7
Eli Lilly & Co.1.67
Daiichi Sankyo Co. Ltd.1.61
Roche Holding Ltd.1.36
Astellas Pharma Inc.1.32
Indicator score from 1 (lowest) to 5 (highest)
GlaxoSmithKline plc3.43
Johnson & Johnson2.93
Novartis AG2.87
Merck KGaA2.83
Merck & Co Inc.2.65
Sanofi2.58
AstraZeneca plc2.53
Gilead Sciences2.45
AbbVie Inc.2.39
Novo Nordisk A/S2.35
Eisai Co. Ltd.2.34
Bayer AG2.03
Bristol-Meyers Squibb Co.1.97
Pfizer Inc.1.87
Takeda Pharmaceutical Co.1.77
Boehringer-Ingelheim GmbH1.7
Eli Lilly & Co.1.67
Daiichi Sankyo Co. Ltd.1.61
Roche Holding Ltd.1.36
Astellas Pharma Inc.1.32
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts the Overall pharmaceutical company ranking of the Access to Medicine Index for developing countries in 2016. In that year, GlaxoSmithKline with 3.43 had the highest total score. The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
Show more
Release date
November 2016
Region
Worldwide
Survey time period
2016
Supplementary notes
* The Access to Medicine Index is an independent initiative that ranks the world’s 20 largest companies according to their efforts to make their products more available, affordable and accessible in developing countries, highlighting policy and practice that either facilitate or hinder access to medicine.
The Index uses a framework that evaluates company activities in seven areas of activity, or technical areas, considered to be key to enhancing access to medicine in developing countries, and across four important aspects of action, or strategic pillars.
A score of zero means lowest and five signifies highest indicator score among the company set.
Merck & Co., Inc. is known as MSD outside the US and Canada. Merck KGaA’s healthcare division is known as EMD Serono in the US and Canada.
Roche declined to provide data to the 2016 Access to Medicine Index. It referred to the fact that oncology, which is not in the Index scope, is its main focus for improving access to medicine. Roche has been included in the Index as it can also improve access in areas in scope where it has products and expertise. Publically available data, along with information from past submissions, were used to assess its performance.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Johnson & Johnson

All Information
in one Presentation

Johnson & Johnson

Everything On "Johnson & Johnson" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Johnson & Johnson"

  • Key Figures
The most important statistics
  • Johnson & Johnson's Impact on the Pharmaceutical Market
The most important statistics
  • Johnson & Johnson's Impact on the Medical Devices & Diagnostic Market
The most important statistics
  • Johnson & Johnson's Impact on the Cosmetic Market
The most important statistics
  • Forecasts
The most important statistics
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News